Fundraising Fox
Eutropics Pharmaceuticals
Cambridge, US · Founded 2005 · Delaware corporation · 6 employees on LinkedIn · 1 known investors
Find your way into Eutropics Pharmaceuticals
Sign up to see every warm intro you have to Eutropics Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eutropics Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MC
Michael CardonePresident/CEOMichael Cardone has over 15 years of experience in oncology therapeutics, diagnostics development, and small company management. At Eutropics Pharmaceuticals, he leads the companion diagnostics platform and business development, including CLIA-certified laboratory services for molecular diagnostic testing.
Investors · 1
MassVenturesreportedWaltham · $250K – $500K
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$350K disclosed across 1 of 2 rounds · 2021–2024
▶$350KofferedJan 2024 · PharmaceuticalsRule 506(b)
▶$350KofferedJan 2024 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael CardoneExecutive Officer, Director
- Offering amount
- $350K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$350KraisedNov 2021 · 5 investors · PharmaceuticalsRule 506(b)
▶$350KraisedNov 2021 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael CardoneExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $350K
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Eutropics Pharmaceuticals's investors?
- Eutropics Pharmaceuticals's investors include MassVentures.
- How much funding has Eutropics Pharmaceuticals raised?
- Eutropics Pharmaceuticals has disclosed $350K raised across 1 of its 2 known rounds.
- Where is Eutropics Pharmaceuticals headquartered?
- Eutropics Pharmaceuticals is headquartered in Cambridge, US.